Posts tagged “NCBIO”
Venture capital investments in medical device companies are down significantly, 20 percent across the country, and the Southeast Medical Device Association (SEMDA) plans to do something about it, says Jason Rupp, executive director.
Sam Taylor, NCBIO president, says that over the next two years, hNorth Carolina biotech manufacturers will need about 2,000 additional workers. Lobbying for full funding of North Carolina State University's biotech training program is thus a priority for NCBIO in 2017.
So much of the deserved media hype about the growing success of the Research Triangle focuses on high tech. Nothing wrong with that. But too often overlooked is the continuing growth of the region's life science industry. And the CED Life Science Conference event next week will showcase that story.
Nearly 50 entrepreneurial life science companies will be getting plenty of "face time" with potential investors at the upcoming CED Life Science conference. Companies from across N.C. and several other states make the list.
North Carolina life science pacesetter and investor Art Pappas, managing partner of venture capital firm Pappas Ventures, will receive the Council for Entrepreneurial Development's 2017 Life Science Leadership Award.
Past and present commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development's 26th annual Life Science Conference next month in Raleigh.
If your early-stage life science company needs some funding help, you still have a few days to apply for a chance to pitch your company story to investors and colleagues at the 2016 annual Southeast BIO Investor & Partnering Forum.
Power pro-business advocacy groups who also have a focus on or include members of the high tech and life science industries are either analyzing the recently passed Public Facilities Privacy & Security Act or steering clear of any comment.
From gene editing to microbiome, precision medicine to big data and more: NC's bright biotech future
Doug Edgeton, CEO of the North Carolina Biotechnology Center, gave a thumb's up overview about the state's life science sector in a briefing to the boards of the Biotech Center, the CED and NCBio earlier this week. Here's a recap.
NCBIO, the trade organization for North Carolina biotechnology companies, expects about 200 to 250 at its annual meeting at the NC Biotechnology Center Thursday. Sam Taylor, NCBIO president, said that in addition to two key note speakers, the event includes a review of state and federal policies related to biotech, including what the NC legislature did this year.
Thirteen emerging startup life science companies will share the spotlight at the annual Life Science Conference put on by the Council for Entrepreneurial Development, NCBIO and the North Carolina Biotechnology Center in Raleigh.
"Innovation isn't important simply because it creates something new - it's only important if what it creates makes a meaningful and positive difference in people's lives," says FDA Commissioner Dr. Margaret Hamburg.
LabCorp, the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for "Venture Day" at the CED's annual life science conference.
Dr. Jack Szostak, a 2009 Nobel Prize winner and a professor of genetics at Harvard, headlines the program for the 22nd CED Life Science Conference next month.
The N.C. Biotechnology Center and other representatives for the state's biotech industry will have a new 3,000 square foot pavillion at the BIO International Convention.